DECEPTION AT DUKE: Chemotherapy can be a tough, even debilitating road for people with cancer. Which is why five years ago, when Duke University announced that it had an advanced, experimental treatment that would match chemotherapy to a patient’s own genetic makeup, it was hailed as the holy grail of cancer care.
However, when other scientists set out to verify Duke’s data, they found many problems and errors. What our 60 Minutes investigation reveals is that Duke’s so-called breakthrough treatment wasn’t just a failure -- it may end up being one of the biggest medical research frauds ever.
Scott Pelley investigates, Sunday at 7 p.m. on 60 Minutes.
